Suneel's Light Foundation

What Suneel's Light Foundation does

Suneel's Light Foundation is a 501(c)(3) charitable nonprofit incorporated in 2002 and headquartered at 275 Northpointe Parkway, Suite 50, Amherst, New York. The foundation is named after Suneel Ram, who was diagnosed with Duchenne Muscular Dystrophy (DMD) at age 2½, and was established by his mother, Dr. Neera Gulati, MD, to fund research toward DMD treatments and a cure while supporting affected families. Over the past two decades, the organization has raised more than $1.5 million cumulatively through donations, fundraising events, corporate sponsorships, and volunteer-driven campaigns, and its research funding contributed to the FDA's September 2016 accelerated approval of eteplirsen (Exondys 51), the first disease-modifying drug for DMD.

The foundation operates four core program areas: (i) a Research Funding Program that has historically directed capital to Sarepta Therapeutics and Akashi Therapeutics; (ii) a Patient Support Program that has financed Wilmington Robotic Exoskeleton (WREX) arms for twelve local boys and now includes the August 2024-launched Brighter Days Community Support Fund, which committed $50,000 in its inaugural year and was expanded from 30 Upstate New York counties to statewide coverage, administered in partnership with the Jett Foundation; (iii) an Advocacy and Awareness Program in which founder Dr. Neera Gulati has testified at FDA advisory-panel meetings; and (iv) educational content publishing, including the 2023 Zuiker Press graphic novel 'Soaring: A Story of Courage' (distributed to more than 200 Western New York schools) and the 'Women in the City of Good Neighbors' coffee-table book.

The business model is a community-led, donation-driven nonprofit GTM: voluntary contributions via website/phone and at events (e.g., Night to Shine), supplemented by retail book sales through Amazon, Barnes & Noble, Books-A-Million, Bookshop, IndieBound, and Indigo. There is no proprietary technology platform; digital infrastructure is limited to a Wix-hosted website and PayPal checkout. Governance is provided by a board led by President Thomas Maher, CPA, CPC, with no paid executive officers disclosed, no parent company, and no institutional capital — the foundation is wholly independent and donor-funded.

Name

Suneel's Light Foundation

Legal name

Suneel's Light Research Foundation

Website

https://suneelslight.com

Company type

Private

Founded year

2002

Operating status

Operating

Short description

Suneel's Light Foundation is a 501(c)(3) charitable nonprofit founded in 2002 in Amherst, New York that funds Duchenne Muscular Dystrophy research, provides financial assistance and assistive devices to affected families in New York State, and advocates for FDA approval of DMD treatments.

Ownership category

akta.pro rank

Product category

Nonprofit Foundation Services

NAICS

Voluntary Health Organizations (813212), Grantmaking Foundations (813211), Other Individual and Family Services (624190)

SIC

Services-Social Services (8300), Services-Health Services (8000), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)

akta.pro secondary industry

Health & Medical Research Grantmaking Foundations (BPAGAKAL)

Keywords

• Nonprofit foundation
• Disease research funding
• Family support grants
• Patient advocacy services
• Community fundraising

Headquarters

HQ city

Amherst

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Donations and Fundraising: The foundation raises funds through donations, fundraising events, corporate sponsorships, and volunteer-driven campaigns. Over two decades, the organization has raised more than $1.5 million to support research, family assistance, and advocacy efforts.
2. Book Sales - Soaring: A Story of Courage: Suneel's Light Foundation publishes and sells the book 'Soaring: A Story of Courage' by Suneel Ram. Copies are available through online retailers (Amazon, Barnes & Noble, Books-A-Million, Bookshop, IndieBound, Indigo) and local book sellers. The foundation also sold the 'Women in the City of Good Neighbors' coffee-table book ($20 per book, $25 for two) with proceeds supporting the foundation.
3. Grant Program Contributions: Suneel's Light Foundation committed $50,000 for the inaugural year of the Brighter Days Community Support Fund, administered by the Jett Foundation, to provide financial aid to qualified families affected by DMD in Upstate New York.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Suneel's Light Foundation is a 501(c)(3) charitable foundation that funds research aimed at treatments and a cure for Duchenne Muscular Dystrophy (DMD) and provides direct financial, emotional, and assistive-device support to families affected by the disease. Its core offerings include research grants to DMD therapeutics developers (e.g., Sarepta Therapeutics, Akashi Therapeutics), the Brighter Days Community Support Fund for NY State families, the Patient Support Program (e.g., WREX robotic arms), and advocacy including FDA advisory-panel testimony. The foundation also publishes and sells books such as "Soaring: A Story of Courage" to raise awareness and funds.

Product overview

Suneel's Light Foundation is a charitable organization (501(c)(3)) established in 2002, not a technology product company. The foundation's offerings center around funding DMD research, providing patient and family support, and advocacy. The core programs include: the Brighter Days Community Support Fund (a grant program administered with the Jett Foundation for financial assistance to NY families), the Research Funding Program (funding for DMD treatments and cure research), Patient Support Programs (including WREX robotic exoskeleton arms), and Advocacy/Awareness initiatives. Additionally, the foundation produces educational publications including the graphic novel 'Soaring: A Story of Courage' by Suneel Ram (published 2023) and the 'Women in the City of Good Neighbors' book. Over two decades, the foundation has raised more than $1.5 million to advance these mission-driven programs.

Differentiator

Problem solved

Functional benefit

Products and services

• Brighter Days Community Support Fund Grant program providing financial aid to qualified families and individuals residing in New York State affected by Duchenne Muscular Dystrophy. Eligible expenses include rent/mortgage assistance, utilities, transportation, food, adaptive devices, and medical care. The program is administered by the Jett Foundation.
• Research Funding Program Funding for innovative research projects that advance understanding of DMD, accelerate development of effective therapies, and ultimately find a cure. Recipients include biotech and pharmaceutical companies working on DMD treatments.
• Patient Support Program Programs tailored to unique needs of DMD patients and families, including access to medical resources, financial assistance for daily challenges, emotional support, community connections, and provision of assistive devices such as Wilmington Robotic Exoskeleton (WREX) arms.
• Advocacy and Awareness Program National advocacy efforts including testimony at FDA advisory-panel meetings and government agencies to advocate for fast-track status for promising DMD treatments. Provides resources and guidance to families navigating insurance appeals processes.
• Soaring: A Story of Courage Graphic novel by Suneel Ram, published by Zuiker Press in 2023, sharing his personal experience living with Duchenne Muscular Dystrophy. Part of a series designed to spotlight young writers with heartfelt stories. Copies distributed to teachers and students at over 200 schools in Western New York.
• Women in the City of Good Neighbors Coffee-table book featuring photographs and biographical sketches of 42 accomplished women in Western New York. Published by Suneel's Light Foundation; proceeds support the foundation's mission to fund DMD research.

Quantifiable outcome

• Life expectancy of DMD patients has increased by 10 years due to advances in research and treatment
• +2 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Partnerships

Three partnerships are on record, tiered core, flagship and minor.

• Jett FoundationcoreStrategic or Co-development Partner · 22 July 2024Suneel's Light Foundation partnered with Jett Foundation to administer the Brighter Days Community Support Fund, providing financial aid to qualified families in Upstate New York affected by DMD. Jett Foundation, headquartered in Plymouth, Massachusetts, was chosen for its extensive experience administering similar emergency fund programs and providing transparent, equitable application processes. The partnership leverages Jett Foundation's expertise to support families across 30+ counties in New York State.
• Zuiker PressflagshipStrategic or Co-development Partner · 1 January 2023Suneel's Light Foundation provided financial support to publish 'Soaring: A Story of Courage,' a graphic novel by Suneel Ram created with Anthony Zuiker (creator of CSI). The foundation helped make copies available to teachers and students at more than 200 schools in Western New York to raise awareness of DMD. Zuiker Press is an issue-based publishing company that champions young authors' voices.
• Glory Be To KidsminorStrategic or Co-development PartnerGlory Be To Kids co-sponsored funding for Wilmington Robotic Exoskeleton arms (WREX) for twelve local boys suffering from DMD, working in partnership with Suneel's Light Foundation to provide assistive devices.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Others

• Sarepta Therapeutics: Commercial-stage DMD pharmaceutical company that received Suneel's Light research funding leading to eteplirsen FDA approval. Ecosystem participant rather than direct peer, but central to the foundation's research impact narrative.
• Akashi Therapeutics: Clinical-stage DMD drug developer (HT-100) that received research funding from Suneel's Light. Not a peer in the same category but a key research partner — listed as an ecosystem participant for sector context.

Broad incumbents

• National Organization for Rare Disorders (NORD): Umbrella organization representing the rare disease community including DMD. Comparable as a voluntary health organization focused on rare diseases, though broader in scope than Suneel's Light's single-disease focus.
• Muscular Dystrophy Association (MDA): Large established nonprofit funding research and care for muscular dystrophy (including DMD) along with ALS and dozens of other neuromuscular diseases. Broad incumbent operating a much larger research and clinic network than Suneel's Light.

Direct peers

• Charley's Fund: DMD-focused venture philanthropy fund investing in biotechnology research for Duchenne treatments. Highly comparable mission — funding translational research to develop therapies for DMD — with a smaller, family-founded profile similar to Suneel's Light.
• Jett Foundation: Direct peer DMD-focused nonprofit that administers Suneel's Light's Brighter Days Community Support Fund. Operates emergency financial assistance programs and community support for DMD families nationally — directly comparable mission and beneficiary base.
• Alex's Lemonade Stand Foundation: Disease-specific (childhood cancer) research and family support nonprofit with comparable dual model of funding research grants and direct family assistance. Strong comparable on operational structure and donor engagement model.
• Parent Project Muscular Dystrophy (PPMD): Large DMD-focused nonprofit funding research, advocacy, and patient support for Duchenne and Becker muscular dystrophy. Direct peer in the same disease-specific niche with overlapping programs in research funding, FDA advocacy, and family services.
• CureDuchenne: DMD-focused venture philanthropy nonprofit funding research and clinical trials for Duchenne treatments. Direct peer with similar dual focus on accelerating therapeutic development and supporting affected families.

Emerging players

• Beyond Batten Disease Foundation: Family-founded rare disease nonprofit funding research and supporting affected families. Comparable scale and structure to Suneel's Light with a similar family-driven origin story focused on a single rare genetic disease.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/suneels_light
• Facebookfacebook.com/Suneelslight
• Instagraminstagram.com/suneels_light

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Suneel's Light Foundation